 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Sanofi
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-09-10 Sale | 2019-09-12 5:00 pm | REGENERON PHARMACEUTICALS Inc | REGN | Sanofi 10% Owner | 172,904 | $281.1 | $48,611,806 | 20,550,812 (Indirect Direct) | View |
| 2019-07-22 Purchase | 2019-07-23 11:39 am | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 93,750 | $16 | $1,500,000 | 558,035 (Indirect) | View |
| 2019-03-08 Sale | 2019-03-12 8:19 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 131,115 | $412.2 | $54,041,315 | 20,723,716 (Indirect Direct) | View |
| 2019-02-13 Sale | 2019-02-15 06:05 am | MyoKardia Inc | MYOK | Sanofi 10% Owner | 4,168,899 | $37.66 | $157,000,736 | 0 (Indirect) | View |
| 2018-09-06 Sale | 2018-09-10 5:01 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 104,552 | $406.7 | $42,519,248 | 23,654,384 (Indirect) | View |
| 2018-06-08 Sale | 2018-06-11 4:30 pm | REGENERON PHARMACEUTICALS INC | REGN | Sanofi 10% Owner | 121,601 | $309.3 | $37,611,882 | 23,758,936 (Indirect) | View |
| 2018-05-25 Purchase | 2018-05-29 4:34 pm | MyoKardia Inc | MYOK | Sanofi 10% Owner | 150,000 | $49 | $7,350,000 | 4,168,899 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-07-22 Conversion | 2019-07-23 11:39 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 464,285 | $0 | 558,035 (Indirect) | View |
| 2019-07-22 Conversion | 2019-07-23 11:39 am | N/A N/A | Fulcrum Therapeutics Inc. | FULC | Sanofi 10% Owner | 3,250,000 | $0 | 558,035 (Indirect) | View |